-
Mashup Score: 0Mental Health Awareness Month - 11 hour(s) ago
Write to us now to be part of our series focused on mental health awareness this
Source: www.psychiatrictimes.comCategories: General Medicine News, PsychiatryTweet
-
Mashup Score: 1Presenting Our May Theme: Mental Health Awareness - 11 hour(s) ago
Write to us now to be part of our series focused on mental health awareness this month.
Source: www.psychiatrictimes.comCategories: General Medicine News, PsychiatryTweet
-
Mashup Score: 0Histamine: Psychiatry’s Neglected Monoamine - 12 hour(s) ago
Understanding the heterogeneity and complexities of the histamine monoamine system.
Source: www.psychiatrictimes.comCategories: General Medicine News, PsychiatryTweet
-
Mashup Score: 1Latest Advancements: Treating Challenging-to-Treat Depression - 12 hour(s) ago
In this episode of PsychPearls, Michael Asbach, DMSc, PA-C, Associate Director of Interventional Psychiatry at DENT Neurologic Institute, and Patricia Cabrera, MD, Group Medical Director for Mood at Johnson & Johnson, discuss the prevalence and burden of challenging-to-treat depression, as well as the evolution of the depression treatment landscape. This episode of PsychPearls is sponsored by Johnson & Johnson. Podcast Intro: Welcome to PsychPearls podcast by Psychiatric Times with thoughtful insights
Source: www.psychiatrictimes.comCategories: General Medicine News, PsychiatryTweet-
#ad Don’t miss this insightful podcast on the prevalence and burden of treatment-resistant depression (TRD), where experts Michael Asbach, DMSc, PA-C, and Patricia Cabrera, MD, dive into the evolution of the TRD treatment landscape. Tune into the episode: https://t.co/NIYljoqgaQ https://t.co/VqnbzCaU0A
-
-
Mashup Score: 2
TEV-‘749, an investigational once-monthly subcutaneous long-acting injection of the 2nd generation antipsychotic olanzapine, sees positive phase 3 results.
Source: www.psychiatrictimes.comCategories: General Medicine News, PsychiatryTweet
-
Mashup Score: 7
The psilocybin did well on safety and efficacy in this phase 2 trial of patients with PTSD.
Source: www.psychiatrictimes.comCategories: General Medicine News, PsychiatryTweet
-
Mashup Score: 5
H. Steven Moffic, MD, received the Abraham Halpern Humanitarian Award at the 2024 American Psychiatric Association Annual Meeting. Here’s what he spoke about during his acceptance.
Source: www.psychiatrictimes.comCategories: General Medicine News, PsychiatryTweet
-
Mashup Score: 0Rolling Submission for Subcutaneous Lecanemab - 6 day(s) ago
Eisai and Biogen announced they have initiated a rolling submission for subcutaneous Leqembi for Alzheimer disease.
Source: www.psychiatrictimes.comCategories: General Medicine News, PsychiatryTweet
-
Mashup Score: 6Antipsychotic Use and Psychiatric Hospitalization in First-Episode Psychosis and Cannabis Use Disorder - 6 day(s) ago
Gone in a puff of smoke? Researchers investigated the effectiveness of antipsychotics in reducing the risk of hospitalization in patients with first-episode psychosis and co-occurring CUD.
Source: www.psychiatrictimes.comCategories: General Medicine News, PsychiatryTweet
-
Mashup Score: 1Carl I. Cohen, MD: Dayenu! It Has to Be Enough - 6 day(s) ago
Remembering the many ways Carl I. Cohen, MD, added to the field of psychiatry.
Source: www.psychiatrictimes.comCategories: General Medicine News, PsychiatryTweet
Welcome to #MentalHealthAwarenessMonth! #MentalHealthMatters https://t.co/pm5UteDmul https://t.co/cgM0BAwjsS